Patent intelligence · US
US 8124059
Stabilized aqueous aluminum zirconium solutions
Stabilized aqueous aluminum zirconium solutions
Patent details — US 8124059
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 28, 2012
- Expiration
- Feb 23, 2032
- Applicant
- Summit Research Labs, Inc.
- Claims
- 10
- CPC classes
- A61K, A61K8/28
Quick answer
US 8124059 (Stabilized aqueous aluminum zirconium solutions) is held by Summit Research Labs, Inc.. Status: granted. Granted Feb 28, 2012. Expires Feb 23, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Summit Research Labs, Inc.
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K8/28
More from Summit Research Labs, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12318487
Solid tablet dosage form of ridinilazole
granted -
US 11344575
Vascular calcification prevention and treatment
granted -
US 11007171
Treatment and prevention of joint disorders
granted -
US 9763925
Antibacterial compounds
granted -
US 9492433
Pharmaceutical composition for the treatment of Duchenne muscular dystrophy
granted -
US 9314456
Antibacterial compounds
granted -
US 9278091
Compounds for the treatment of Clostridium difficile associated disease
granted -
US 8987308
Compounds for the treatment of Clostridium difficile-associated disease
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 8124059?
US 8124059 (Stabilized aqueous aluminum zirconium solutions) is held by Summit Research Labs, Inc.. Status: granted. Granted Feb 28, 2012. Expires Feb 23, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8124059?
Summit Research Labs, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 20 pharmaceutical patents for this assignee.
When does US 8124059 expire?
Our index shows an expiration date of Feb 23, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.